| Trial Identifier: | D6520C00001 |
| Sponsor: | AstraZeneca |
| NCTID:: | NCT03205176 |
| Start Date: | June 2017 |
| Primary Completion Date: | March 2021 |
| Study Completion Date: | April 2021 |
| Condition: | Breast Cancer; Lymphoma; Cancer - Other; Ovarian Cancer; Pancreatic Cancer; Prostate Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| English Version |
| Country | Location |
|---|---|
| CA, CA | Toronto, CA, CA, M5G 2M9 |
| US, FL | Sarasota, FL, US, 34232 |
| US, OK | Oklahoma City, OK, US, 73104 |
| US, TN | Nashville, TN, US, 37203 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company